Skip To Main Content

This website is intended exclusively for healthcare professionals residing and/or working in Oman.

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Over 80% of CRS with Nasal Polyps’ Patients have Type 2 Inflammation Dupixent is the first and only biologic to inhibit il-4 and il-13 signaling in crs with nasal polyps.

Related articles

Hear from an expert on what does Dupixent bring to your practice?

Hear from an expert on what does Dupixent bring to your practice?

Expert Opinions: Would You Consider A Biologic For A CRSwnp Patient Who Has Had Sinus Surgery?

Expert Opinions: Would You Consider A Biologic For A CRSwnp Patient Who Has Had Sinus Surgery?

Hear From An Expert On What Have You Learned From Your Experience With Biologics?

Hear From An Expert On What Have You Learned From Your Experience With Biologics?

MAT-KW-2400275/V1/MAY2024